Phyo T. Htoo

Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease

Elisabetta Patorno, Phyo T. Htoo, Robert J. Glynn et al. · Annals of Internal Medicine · 2021 · 101 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

A Comparison of the Effects of Epidural Analgesia Versus Traditional Pain Management on Outcomes After Gastric Cancer Resection

Kenneth C. Cummings, Meatal Patel, Phyo T. Htoo et al. · Regional Anesthesia & Pain Medicine · 2014 · 40 citations · Full text

Medicine, Oncology, Surgery +17

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics

Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiß et al. · JAMA Network Open · 2022 · 32 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacotherapy +17

Cardiovascular Effectiveness of Sodium‐Glucose Cotransporter 2 Inhibitors and Glucagon‐Like Peptide‐1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure

Phyo T. Htoo, John B. Buse, Matthew A. Cavender et al. · Journal of the American Heart Association · 2022 · 30 citations · Full text

Pharmacy, Cardiology, Pharmacology +17

Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors

Phyo T. Htoo, John B. Buse, Mugdha Gokhale et al. · European Journal of Clinical Pharmacology · 2016 · 25 citations

Medicine, Oncology, Pharmacology +13